In a collagen-induced arthritis model, oral L. casei therapy inhibited the cyclooxygenase-2 (COX-2) enzyme and reduced chemokines, leading to anti-inflammatory benefits in rats. The gene discussed is PTGS2; the disease is arthritic joint disease.